{
  "main_header": {
    "sid": 736142,
    "name": "Welcure Drugs",
    "stock_name": "Welcure Drugs",
    "full_name": "Welcure Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/welcure-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.45",
    "chg": -0.01,
    "chgp": "-2.17%",
    "dir": -1,
    "prev_price": "0.46",
    "mcapval": "54.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524661,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE331C01025",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "1.15 cr",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/welcure-drugs-736142-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Welcure Drugs & Pharmaceuticals Falls to 52-Week Low of Rs.0.44",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-falls-to-52-week-low-of-rs044-3760970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_priceRelatedfactors_3760970.png",
        "date": "2025-12-17 09:48:05",
        "description": "Welcure Drugs & Pharmaceuticals has reached a new 52-week low, closing at Rs.0.44 today, marking a significant decline amid broader market stability. The stock has underperformed its sector and the benchmark indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology industry."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Falls to 52-Week Low of Rs.0.46",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-falls-to-52-week-low-of-rs046-3756209",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_priceRelatedfactors_3756209.png",
        "date": "2025-12-11 09:59:03",
        "description": "Welcure Drugs & Pharmaceuticals has reached a new 52-week low of Rs.0.46, marking a significant decline in its stock price amid a broader market environment where the Sensex remains near its yearly highs. The stock has experienced a sustained downward trend over the past four days, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Welcure Drugs Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-downgraded-to-sell-by-marketsmojo-amid-weak-fundamentals-3749935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugs_mojoScore_3749935.png",
        "date": "2025-12-06 10:10:05",
        "description": "Welcure Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a shift in analytical perspective. This adjustment follows a detailed review of the company’s financial and technical parameters, highlighting a complex interplay of strengths and weaknesses that investors should carefully consider."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-faces-intense-selling-pressure-amid-lower-circuit-3746824",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_only_sellers_3746824.png",
        "date": "2025-12-04 13:25:47",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buying interest. The pharmaceutical company’s shares have fallen for two consecutive sessions, reflecting distress selling signals and a challenging market environment."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3744247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_only_sellers_3744247.png",
        "date": "2025-12-03 12:00:38",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is currently experiencing significant selling pressure, with the stock registering a sharp decline and only sell orders visible in the market queue. This distress selling signals a challenging phase for the company amid broader market fluctuations."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Surges with Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-hits-upper-circuit-amidst-unprecedented-buying-frenzy-3740993",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_only_buyers_3740993.png",
        "date": "2025-12-02 09:36:02",
        "description": "Welcure Drugs & Pharmaceuticals has captured market attention with an extraordinary surge in buying activity, registering a 3.64% gain today while the broader Sensex declined by 0.25%. The stock’s unique position of having only buy orders in the queue signals a potential multi-day upper circuit scenario, reflecting robust investor enthusiasm amid a challenging market backdrop."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Hits Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-hits-upper-circuit-amidst-unprecedented-buying-interest-3738526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_only_buyers_3738526.png",
        "date": "2025-12-01 11:25:41",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has witnessed extraordinary buying momentum today, with the stock hitting its upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and a complete absence of sellers, signalling a potential multi-day circuit scenario for the pharmaceutical company."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-faces-severe-selling-pressure-amid-lower-circuit-3724277",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/WelcureDrugsPha_only_sellers_3724277.png",
        "date": "2025-11-24 09:50:32",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. This distress selling signals a challenging phase for the company amid a broader market environment where the Sensex remains steady."
      },
      {
        "title": "Why is Welcure Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-welcure-drugs-fallingrising-3722089",
        "imagepath": "",
        "date": "2025-11-22 01:01:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Welcure Drugs’ recent price action reflects a brief respite in an otherwise challenging year for the stock. While it gained 3.57% on 21-Nov, the stock remains significantly down over multiple time frames. Year-to-date, the share price has declined by 44.78%, contrasting sharply with the Sensex’s 9.08% gain over the same period. Over the past year, Welcure Drugs has fallen 20.14%, whereas the Sensex advanced 10.47%. Even on a three-year horizon, the stock lags the benchmark, down 6.33% compared to the Sensex’s robust 39.39% rise.</p>\n<p>This disparity highlights the stock’s persistent underperformance despite sporadic rallies. However, the five-year return tells a different story, with Welcure Drugs delivering an impressive 228.80% gain..."
      }
    ],
    "total": 256,
    "sid": "736142",
    "stock_news_url": "https://www.marketsmojo.com/news/welcure-drugs-pharmaceuticals-736142"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Saturday December 06 2025",
      "datetime": "06-Dec-2025",
      "details": "Outcome of the Meeting of the Board of Directors of Welcure Drugs and Pharmaceuticals Limited held today i.e. Saturday December 06 2025",
      "source": "BSE"
    },
    {
      "caption": "Postponement Of The Meeting Of The Rights Issue Committee Of Welcure Drugs And Pharmaceuticals Limited Which Was To Be Held Today I.E. Monday December 05 2025",
      "datetime": "05-Dec-2025",
      "details": "Postponment of the meeting of the Right Issue Committe of the Welcure Drugs and Pharmaceuticals Limited which was to be held today i.e MondayDecember 052025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Monday December 01 2025",
      "datetime": "01-Dec-2025",
      "details": "Outcome of the Meeting of the Board of Directors of Welcure Drugs And Pharmaceuticals Limited held today i.e. Monday December 01 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Welcure Drugs & Pharmaceuticals Falls to 52-Week Low of Rs.0.44

2025-12-17 09:48:05

Welcure Drugs & Pharmaceuticals has reached a new 52-week low, closing at Rs.0.44 today, marking a significant decline amid broader market stability. The stock has underperformed its sector and the benchmark indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology industry.

Read More

Welcure Drugs & Pharmaceuticals Falls to 52-Week Low of Rs.0.46

2025-12-11 09:59:03

Welcure Drugs & Pharmaceuticals has reached a new 52-week low of Rs.0.46, marking a significant decline in its stock price amid a broader market environment where the Sensex remains near its yearly highs. The stock has experienced a sustained downward trend over the past four days, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Welcure Drugs Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-06 10:10:05

Welcure Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a shift in analytical perspective. This adjustment follows a detailed review of the company’s financial and technical parameters, highlighting a complex interplay of strengths and weaknesses that investors should carefully consider.

Read More

Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-04 13:25:47

Welcure Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buying interest. The pharmaceutical company’s shares have fallen for two consecutive sessions, reflecting distress selling signals and a challenging market environment.

Read More

Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-03 12:00:38

Welcure Drugs & Pharmaceuticals Ltd is currently experiencing significant selling pressure, with the stock registering a sharp decline and only sell orders visible in the market queue. This distress selling signals a challenging phase for the company amid broader market fluctuations.

Read More

Welcure Drugs & Pharmaceuticals Surges with Unprecedented Buying Interest

2025-12-02 09:36:02

Welcure Drugs & Pharmaceuticals has captured market attention with an extraordinary surge in buying activity, registering a 3.64% gain today while the broader Sensex declined by 0.25%. The stock’s unique position of having only buy orders in the queue signals a potential multi-day upper circuit scenario, reflecting robust investor enthusiasm amid a challenging market backdrop.

Read More

Welcure Drugs & Pharmaceuticals Hits Upper Circuit Amidst Unprecedented Buying Interest

2025-12-01 11:25:41

Welcure Drugs & Pharmaceuticals Ltd has witnessed extraordinary buying momentum today, with the stock hitting its upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and a complete absence of sellers, signalling a potential multi-day circuit scenario for the pharmaceutical company.

Read More

Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 09:50:32

Welcure Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. This distress selling signals a challenging phase for the company amid a broader market environment where the Sensex remains steady.

Read More

Why is Welcure Drugs falling/rising?

2025-11-22 01:01:19

Recent Price Movement and Market Context

Welcure Drugs’ recent price action reflects a brief respite in an otherwise challenging year for the stock. While it gained 3.57% on 21-Nov, the stock remains significantly down over multiple time frames. Year-to-date, the share price has declined by 44.78%, contrasting sharply with the Sensex’s 9.08% gain over the same period. Over the past year, Welcure Drugs has fallen 20.14%, whereas the Sensex advanced 10.47%. Even on a three-year horizon, the stock lags the benchmark, down 6.33% compared to the Sensex’s robust 39.39% rise.

This disparity highlights the stock’s persistent underperformance despite sporadic rallies. However, the five-year return tells a different story, with Welcure Drugs delivering an impressive 228.80% gain...

Read More

View All News